An assessment of the effectiveness of the measles immunization programme in Lagos, Nigeria
- 1 February 1981
- journal article
- research article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 75 (1) , 87-92
- https://doi.org/10.1080/00034983.1981.11687412
Abstract
Sera from 224 children (mean age 10·2 months) were tested for the presence of measles haemagglutinating antibodies prior to measles vaccination. Six to eight weeks later, they were re-tested. The sera conversion rate was 53·5%. The geometric mean titre was 60 in the sero-converters. The sero-converters were significantly younger than the non-sero-converters (P<0·02) and their mean age was 9·79 months; the mean age of non-sero-converters was 10·1 months. The proportion of non-sero-converters was higher in those who were at least 12 months old than in younger children. It therefore appeared that the low sero-conversion rate was due to other factors in addition to persistent maternal antibodies because the results were the opposite of what would be expected if only maternal antibodies were responsible. It is postulated that vaccine inactivation due to poor storage is an important cause of non-sero-conversion and a plea is made for an effective ‘cold chain’ from the time of vaccine manufacture to its use in the clinics.This publication has 6 references indexed in Scilit:
- Present status of measles and rubella immunization in the United States: A medical progress reportThe Journal of Pediatrics, 1977
- Measles vaccination: Studies in methods and cost reduction in developing countriesTransactions of the Royal Society of Tropical Medicine and Hygiene, 1971
- Studies on immunity to measlesThe Journal of Pediatrics, 1965
- A FURTHER STUDY ON MEASLES VACCINATION IN NIGERIAN CHILDREN1965
- Propagation in Tissue Cultures of Cytopathogenic Agents from Patients with Measles.Experimental Biology and Medicine, 1954